Literature DB >> 29068791

Transfusion-associated necrotizing enterocolitis re-evaluated: a systematic review and meta-analysis.

Stientje Esther Rai1,2, Amneet Kaur Sidhu1,2, Rohin Jayaram Krishnan2.   

Abstract

CONTEXT: Significant controversy exists surrounding the possible association between recent packed red blood cell (PRBC) transfusion and the subsequent development of necrotizing enterocolitis (NEC) in infants. Previous studies and meta-analyses reporting a statistically significant association led to a practice change to withhold enteral feeds in the peri-transfusion period in many centers in an effort to prevent NEC; however, results from more recent studies do not support the existence of an association and, thus, question the validity of this practice change.
OBJECTIVE: This study aimed to perform a systematic review and meta-analysis to determine whether exposure to recent PRBC transfusion (defined as within 48 h) is associated with the subsequent development of NEC stage ≥II (Bell's criteria) in infants.
METHODS: Medline, Embase, CINAHL, and the Cochrane Library were searched from inception to October 7, 2015. A gray literature search was also performed. Studies comparing the risk of NEC in infants exposed and unexposed to recent PRBC transfusion were included. Thirteen studies met eligibility criteria, and 10 (n=15,675 infants) were included in the meta-analysis. Three authors independently extracted data, and meta-analysis was performed using a random effects model.
RESULTS: We found a statistically significant 45% reduction in the unadjusted odds of NEC in infants exposed to a recent PRBC transfusion (odds ratio=0.55, 95% confidence interval=0.31-0.98).
CONCLUSION: Our results show a protective effect of recent PRBC transfusion on the subsequent development of NEC. The practice of withholding enteral feeds during the peri-transfusion period should be re-evaluated in light of these results.

Entities:  

Keywords:  Infant; necrotizing enterocolitis; prematurity; transfusion

Mesh:

Year:  2018        PMID: 29068791     DOI: 10.1515/jpm-2017-0048

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  7 in total

1.  Risk of Necrotizing Enterocolitis Following Packed Red Blood Cell Transfusion in Very Low Birth Weight Infants.

Authors:  Waricha Janjindamai; Arunee Prapruettrong; Anucha Thatrimontrichai; Supaporn Dissaneevate; Gulawadee Maneenil; Alan Geater
Journal:  Indian J Pediatr       Date:  2019-02-21       Impact factor: 1.967

2.  Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response.

Authors:  Yong Jing; Fudong Peng; Yufeng Shan; Jingkai Jiang
Journal:  Exp Ther Med       Date:  2018-10-17       Impact factor: 2.447

3.  Current Understanding of Transfusion-associated Necrotizing Enterocolitis: Review of Clinical and Experimental Studies and a Call for More Definitive Evidence.

Authors:  Minesh Khashu; Christof Dame; Pascal M Lavoie; Isabelle G De Plaen; Parvesh M Garg; Venkatesh Sampath; Atul Malhotra; Michael D Caplan; Praveen Kumar; Pankaj B Agrawal; Giuseppe Buonocore; Robert D Christensen; Akhil Maheshwari
Journal:  Newborn (Clarksville)       Date:  2022-03-31

Review 4.  Anemia of prematurity: how low is too low?

Authors:  Catherine C Cibulskis; Akhil Maheshwari; Rakesh Rao; Amit M Mathur
Journal:  J Perinatol       Date:  2021-03-04       Impact factor: 3.225

5.  Novel Strategy to Determine Practice in a Neonatal Intensive Care Unit in Canada.

Authors:  Sriya Roychaudhuri; Mimi Kuan
Journal:  J Med Educ Curric Dev       Date:  2022-04-28

Review 6.  Clinical Characteristics and Potential Pathogenesis of Cardiac Necrotizing Enterocolitis in Neonates with Congenital Heart Disease: A Narrative Review.

Authors:  Kathryn Y Burge; Aarthi Gunasekaran; Marjorie M Makoni; Arshid M Mir; Harold M Burkhart; Hala Chaaban
Journal:  J Clin Med       Date:  2022-07-09       Impact factor: 4.964

7.  Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial.

Authors:  Yong Wang; Juan Song; Huiqing Sun; Falin Xu; Kenan Li; Chunxia Nie; Xiaoli Zhang; Xirui Peng; Lei Xia; Ziyun Shen; Xiao Yuan; Shan Zhang; Xue Ding; Yaodong Zhang; Wenqing Kang; Liling Qian; Wenhao Zhou; Xiaoyang Wang; Xiuyong Cheng; Changlian Zhu
Journal:  J Transl Med       Date:  2020-08-08       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.